GPSM1, GPSM2, and GPSM3 were most highly expressed in triple negative breast cancer cell lines, while GPSM4 showed high expression in multiple luminal A cell lines (Figure 2B). This evidence concerns the gene GPSM2 and triple-negative breast carcinoma.